Allogeneic islet transplantation with monitoring of islet-specific cellular autoimmunity in a Japanese patient with type 1 diabetes: A case report.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Apr 2022
Historique:
revised: 01 11 2021
received: 01 09 2021
accepted: 16 11 2021
pubmed: 19 11 2021
medline: 22 4 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Here, we report a case of allogeneic islet transplantation in Japan. A 48-year-old man received intraportal islet transplantation (5,945 islet equivalent/kg), and stabilization of blood glucose levels and suppression of hypoglycemia were achieved. In the present case, we used our original assessment method to detect the responses of the recipient's T cells to islet autoantigens over time to monitor cellular autoimmunity. Other markers could not predict graft dysfunction in advance, but our method detected the activation of islet antigen-specific CD8

Identifiants

pubmed: 34792297
doi: 10.1111/jdi.13715
pmc: PMC9017629
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-745

Subventions

Organisme : NCGM Intramural Research Fund
ID : 24A002

Informations de copyright

© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

N Engl J Med. 2006 Sep 28;355(13):1318-30
pubmed: 17005949
Lancet. 2005 May 7-13;365(9471):1642-4
pubmed: 15889479
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32652026
Glob Health Med. 2020 Aug 31;2(4):200-211
pubmed: 33330809
J Diabetes Investig. 2019 Jul;10(4):1108-1111
pubmed: 30588765
J Diabetes Investig. 2022 Apr;13(4):741-745
pubmed: 34792297
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18425-30
pubmed: 16339897
Cell Transplant. 2012;21(12):2783-95
pubmed: 22963904
Cell Transplant. 2011;20(10):1641-7
pubmed: 21396171
Clin Immunol. 2015 Dec;161(2):270-7
pubmed: 26341315

Auteurs

Daisuke Chujo (D)

Pancreatic Islet Transplantation Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Diabetes, Endocrinology and Metabolism, National Center for Global health and Medicine, Tokyo, Japan.
Center for Clinical Research, Toyama University Hospital, Toyama, Japan.

Toshiaki Kurokawa (T)

Department of Surgery, JCHO Tokyo Takanawa Hospital, Tokyo, Japan.

Akitsu Kawabe (A)

Pancreatic Islet Transplantation Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Nobuyuki Takahashi (N)

Department of Diabetes, Endocrinology and Metabolism, National Center for Global health and Medicine, Tokyo, Japan.

Fuyuki Inagaki (F)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.

Koya Shinohara (K)

Pancreatic Islet Transplantation Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Shotaro Hagiwara (S)

Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Yoshihiro Edamoto (Y)

Department of Surgery, Secomedic Hospital, Chiba, Japan.

Norio Ohmagari (N)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Fumihiko Hinoshita (F)

Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.

Tsuyoshi Tajima (T)

Radiology, National Center for Global Health and Medicine, Tokyo, Japan.

Hiroshi Kajio (H)

Department of Diabetes, Endocrinology and Metabolism, National Center for Global health and Medicine, Tokyo, Japan.

Hiroshi Ohtsu (H)

Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Nobuyuki Takemura (N)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.

Shinichi Matsumoto (S)

Pancreatic Islet Transplantation Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Masayuki Shimoda (M)

Pancreatic Islet Transplantation Project, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH